Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics

Less than half of severe asthmatic patients show a >80% adherence rate to inhaled treatment just before and during biologic therapy. This has implications in biologic treatment sustainability and disease prevalence estimation.http://bit.ly/3cRTJB0